- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 39/145 - Orthomyxoviridae, p. ex. virus de l'influenza
Détention brevets de la classe A61K 39/145
Brevets de cette classe: 2937
Historique des publications depuis 10 ans
|
208
|
181
|
211
|
204
|
176
|
176
|
199
|
238
|
172
|
115
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Glaxosmithkline Biologicals S.A. | 1603 |
69 |
| Seqirus UK Limited | 430 |
61 |
| Icahn School of Medicine at Mount Sinai | 1044 |
52 |
| Curevac SE | 295 |
51 |
| Wisconsin Alumni Research Foundation | 3901 |
43 |
| Sanofi Pasteur Inc. | 287 |
42 |
| University of Georgia Research Foundation, Inc. | 1078 |
42 |
| Modernatx, Inc. | 1279 |
34 |
| Janssen Vaccines & Prevention B.V. | 270 |
32 |
| The Trustees of the University of Pennsylvania | 4426 |
31 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3007 |
29 |
| Novartis AG | 10178 |
28 |
| Aramis Biotechnologies Inc. | 57 |
28 |
| FluGen, Inc. | 38 |
26 |
| Academia Sinica | 959 |
24 |
| Intervet Inc. | 930 |
24 |
| Longhorn Vaccines and Diagnostics, LLC | 92 |
23 |
| Novavax, Inc. | 177 |
23 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3322 |
23 |
| Seqirus Inc. | 262 |
23 |
| Autres propriétaires | 2229 |